C12Y 306/03001
Phospholipid-translocating atpase , i.e. mg2+-atpase
Official title: Phospholipid-translocating ATPase (3.6.3.1), i.e. Mg2+-ATPase
C12Y306/03001 (Phospholipid-translocating atpase , i.e. mg2+-atpase) appears on 4 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 6
- Assignees
- 5
- Inventors
- 13
- Latest grant
- 20 Jun 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Immunogenic compositions20 Jun 2023US 11,679,149 B2Glaxosmithkline Biologicals SA
- Microorganism strain for high-performance metabolism of biomass-derived carbon source27 Dec 2022US 11,535,854 B2Postech Academy-Industry Foundation
- Glycosylated protein expression in prokaryotes6 Dec 2016US 9,512,434 B2Cornell Research Foundation, Inc.
- Glycosylated protein expression in prokaryotes7 Apr 2015US 8,999,668 B2Cornell Research Foundation, Inc.
- Immunogenic compositions9 May 2024US 2024/0148848 A1Glaxosmithkline Biologicals SA
- Novel microorganism strain for high-performance metabolism of biomass-derived carbon source12 Nov 2020US 2020/0354755 A1Postech Academy-Industry Foundation
- Immunogenic compositions23 Jan 2020US 2020/0023051 A1Glaxosmithkline Biologicals SA
- Glycosylated protein expression in prokaryotes20 Aug 2015US 2015/0232861 A1Cornell Research Foundation, Inc.
- Pseudogenes and uses thereof25 Jul 2013US 2013/0189679 A1The Regents of the University of Michigan
Most cited
By later US patents